Status:

UNKNOWN

Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Familial Mediterranean Fever

Eligibility:

All Genders

1+ years

Phase:

NA

Brief Summary

Familial Mediterranean Fever (FMF) genetic diagnosis is well established for homozygous patients. On the other hand, although heterozygous individuals are theoretically healthy carriers, 1/3 of them w...

Detailed Description

Familial Mediterranean fever (FMF) is a rare autoinflammatory disorder due to mutations in the MEFV (MEditerranean FeVer) gene, that causes recurrent episodes of fever and acute serositis (peritoneum,...

Eligibility Criteria

Inclusion

  • Patient aged ≥1 year
  • Body weight ≥ 10kg
  • Homozygous patients group: patients homozygous for MEFV (M694V, M694I, M680I, V726A)
  • Symptomatic heterozygous patients group: patients heterozygous for the MEFV gene (M694V, M694I, M680I, V726A) meeting the Yalcinkaya criteria for FMF diagnosis (Fever lasting 6 to 72 hours with at least 3 attacks - Abdominal pain of 6 to 72 hours duration with at least 3 attacks - Chest pain of 6 to 72 hours duration with at least 3 attacks - Arthritis of 6 to 72 hours duration with at least 3 attacks- FMF Family History of FMF)
  • Asymptomatic heterozygous patients group: patients heterozygous for the MEFV gene (M694V, M694I, M680I, V726A) who do not meet the Yalcinkaya criteria for FMF diagnosis
  • Control subjects group: absence of identified auto-inflammatory disorder

Exclusion

  • Absence of collection of informed consent of participant or absence of informed consent of the legal representatives/guardians of pediatric participant
  • Subjects not registered in Social Security system

Key Trial Info

Start Date :

October 2 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 2 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06033339

Start Date

October 2 2023

End Date

October 2 2025

Last Update

September 14 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University Hospital of Nîmes

Nîmes, France

2

Robert Debré University Hospital of Paris

Paris, France

3

University Hospital of Paris Kremlin Bicêtre

Paris, France

4

University Hospital of Toulouse

Toulouse, France

Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology | DecenTrialz